David Fuller
Director Técnico/Científico/I+D en DIMERIX LIMITED .
Fortuna: 1 869 $ al 31/05/2024
Cargos activos de David Fuller
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ADALTA LIMITED | Director/Miembro de la Junta | 22/07/2020 | - |
| DIMERIX LIMITED | Director Técnico/Científico/I+D | 23/10/2023 | - |
EpiAxis Therapeutics Pty Ltd.
 EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia. | Presidente | - | - |
Historial de carrera de David Fuller
Antiguos cargos conocidos de David Fuller.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| RACE ONCOLOGY LIMITED | Director Técnico/Científico/I+D | 01/07/2021 | 11/11/2022 |
Estadísticas
Internacional
| Australia | 5 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
| Chairman | 1 |
Sectorial
| Health Technology | 5 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ADALTA LIMITED | Health Technology |
| RACE ONCOLOGY LIMITED | Health Technology |
| DIMERIX LIMITED | Health Technology |
| Empresas privadas | 1 |
|---|---|
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia. | Health Technology |
- Bolsa de valores
- Insiders
- David Fuller
- Experiencia
